Up a level |
Healy, Patricia, Gordijn, Sanne, Ganzevoort, Wessel, Beune, Irene, Baschat, Ahmet, Khalil, Asma, Kenny, Louise ORCID: 0000-0002-9011-759X, Bloomfield, Frank, Daly, Mandy, Papageorghiou, Aris et al (show 1 more authors)
(2018)
Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
TRIALS, 19 (1).
451-.
Healy, Patricia, Gordijn, Sanne J, Ganzevoort, Wessel, Beune, Irene M, Baschat, Ahmet, Khalil, Asma, Kenny, Louise ORCID: 0000-0002-9011-759X, Bloomfield, Frank H, Daly, Mandy, Kirkham, Jamie ORCID: 0000-0003-2579-9325 et al (show 2 more authors)
(2019)
A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE study.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 221 (4).
339.e1-339.e10.
Pels, Anouk, Ganzevoort, Wessel, Kenny, Louise C, Baker, Philip N, von Dadelszen, Peter, Gluud, Christian, Kariya, Chirag T, Leemhuis, Aleid G, Groom, Katie M, Sharp, Andrew N ORCID: 0000-0003-3396-7464 et al (show 4 more authors)
(2023)
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.
The Cochrane database of systematic reviews, 7 (7).
CD014498-.
Liauw, Jessica, Groom, Katie, Ganzevoort, Wessel, Gluud, Christian, McKinlay, Christopher JD, Sharp, Andrew, Mackay, Laura, Kariya, Chirag, Lim, Ken, von Dadelszen, Peter et al (show 30 more authors)
(2021)
Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
Systematic Reviews, 10 (1).
305-.